These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7166584)

  • 1. [Clinical study on reductions of intracranial pressure by therapeutic agents. 2. Effects of glycerol through various administration methods and the rebound phenomenon caused by the agent].
    Node Y
    Nihon Ika Daigaku Zasshi; 1982; 49(6):752-8. PubMed ID: 7166584
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study on reductions of intracranial pressure by therapeutic agents. I. The effects of mannitol through various methods of administration and the rebound phenomenon caused by the agent].
    Node Y
    Nihon Ika Daigaku Zasshi; 1982; 49(6):745-51. PubMed ID: 6820023
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon.
    Node Y; Nakazawa S
    Adv Neurol; 1990; 52():359-63. PubMed ID: 2118716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glycerol for the treatment of traumatic intracranial hypertension.
    Wald SL; McLaurin RL
    J Neurosurg; 1982 Mar; 56(3):323-31. PubMed ID: 7057229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycerol administration: alternative method and review.
    Massey EW; Brannon WL
    Mil Med; 1977 Sep; 142(9):696-8. PubMed ID: 408758
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain oedema and intracranial hypertension treatment by GLIAS.
    Oppido PA; Delfini R; Innocenzi G; Di Giugno G; Pecori-Giraldi J; Santoro A; Virno M; Cantore GP
    Acta Neurochir Suppl (Wien); 1992; 55():40-2. PubMed ID: 1414543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous glycerol in increased intracranial tension.
    Phadke AS; Upasani SS; Upassani SP; Prayag VS; Salnani GS
    J Assoc Physicians India; 1976 Mar; 24(3):147-51. PubMed ID: 1010813
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monitoring intracranial pressure in pseudotumor cerebri. Apropos of 2 cases].
    Eizaguirre I; García Goicoechea M; García Goicoechia M; Albisu Y; Navajas B; Pérez-Yarza EG
    An Esp Pediatr; 1982 Jun; 16(6):520-3. PubMed ID: 7125404
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rebound phenomenon of mannitol and glycerol: clinical studies].
    Node Y; Yajima K; Nakazawa S
    No To Shinkei; 1983 Dec; 35(12):1241-6. PubMed ID: 6422967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series.
    Schoeman JF
    J Child Neurol; 1994 Apr; 9(2):130-4. PubMed ID: 8006361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebound phenomenon.
    Javid M; Levin A; Duff T; Gilboe D
    J Neurosurg; 1982 Jul; 57(1):153. PubMed ID: 7086495
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of increased intracranial pressure by barbiturate therapy in a patient with severe sinus thrombosis after failure of osmotic therapy. A case report.
    Maruishi M; Kato H; Nawashiro H; Takiguchi H; Shima K; Chigasaki H
    Acta Neurochir (Wien); 1993; 120(1-2):88-91. PubMed ID: 8434523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebound phenomenon complicating cerebral dehydration with glycerol. Case report.
    Guisado R; Tourtellotte WW; Arieff AI; Tomiyasu U; Mishra SK; Schotz MC
    J Neurosurg; 1975 Feb; 42(2):226-8. PubMed ID: 163300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of mannitol and glycerol on the reduction of raised intracranial pressure and on their rebound phenomenon].
    Node Y; Yajima K; Nakazawa S
    No Shinkei Geka; 1983 Mar; 11(3):259-67. PubMed ID: 6406923
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of beta-blockers in the treatment of idiopathic intracranial hypertension (physiopathogenetic basis)].
    Salvanet-Bouccara A; Mandelbaum-Stupp C
    J Fr Ophtalmol; 1985; 8(8-9):535-9. PubMed ID: 4086729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycerol: a review of its pharmacology, pharmacokinetics, adverse reactions, and clinical use.
    Frank MS; Nahata MC; Hilty MD
    Pharmacotherapy; 1981; 1(2):147-60. PubMed ID: 6927604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between dopamine infusions and intracranial hemodynamics in patients with raised intracranial pressure.
    Nau R; Sander D; Klingelhöfer J
    Clin Neurol Neurosurg; 1992; 94(2):143-8. PubMed ID: 1324812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin as a treatment for patients with idiopathic intracranial hypertension.
    Haagensen J; Hoegerl C
    J Am Osteopath Assoc; 2014 Mar; 114(3):213-5. PubMed ID: 24567274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-assisted analysis of intraventricular pressure after mannitol administration.
    Szewczykowski J; Sliwka S; Kunicki A; Korsak-Sliwka J; Dziduszko J; Dytko P; Augustyniak B
    J Neurosurg; 1975 Aug; 43(2):136-41. PubMed ID: 1185246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous glycerol and mannitol therapy in children with intracranial hypertension.
    MacDonald JT; Uden DL
    Neurology; 1982 Apr; 32(4):437-40. PubMed ID: 6801542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.